Powles, T., Heijden, M. S. V. D., Loriot, Y., Bedke, J., Valderrama, B. P., Iyer, G., Kikuchi, E., Hoffman-Censits, J., Vulsteke, C., Drakaki, A., Rausch, S., Arafat, W., Park, S. H., Swami, U., Li, J., Gorla, S. R., Moreno, B. H., Yu, X., Lu, Y., Gupta, S. (2025). EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.664